English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 19 October 2017, 16:00 HKT/SGT
Share:
        

Source: Holista CollTech Ltd / Holista Foods Inc.
ASX-Listed Holista and Holista Foods Inc. (USA) Develop Breakthrough Noodle Formula with Low-Glycemic Score of 38
To Secure First Order Before End of 2017

Perth, Kuala Lumpur and Ontario, Oct 19, 2017 - (ACN Newswire) - Australian Securities Exchange-listed food ingredient specialist Holista CollTech Ltd (ASX: HCT, "Holista") announced today that it has developed a breakthrough noodle formula certified to have a low Glycemic Index ("GI") - opening a major market for a healthier version of the staple which is vital in the global fight against diabetes and obesity.

The noodles developed by Holista's Buffalo, New York-based U.S. subsidiary of Holista Foods Inc. ("Holista Foods"), recorded a GI reading of 38 in independent tests conducted by Glycemic Index Laboratories, Inc, Toronto, Canada. The global average GI reading for noodles is 60.

The GI reading indicates the rate in which foods containing carbohydrates raise blood sugar levels in humans, with a lower score indicating healthier food. More than 100 million adult Americans suffer from diabetes or prediabetes, according to the Center for Disease Control and Prevention. 11 million Canadians are living with the disease.

The Diabetes Canada has endorsed Holista Foods' low-GI noodle formula as having met the latter's dietary guidelines. Holista Foods is allowed to display the Diabetes Canada logo on its product.

In addition to the low GI reading of 38, each 85 gram serving of noodles contains 11 grams of protein, three grams of fibre, zero sugar, low sodium, low cholesterol and clean label ingredients (no artificial ingredients or preservatives) and cooks in just three minutes.

Holista Foods will showcase the low-GI noodles at the 2017 Food & Nutrition Conference & Expo in Chicago, Illinois, from October 21-24, and at the 2017 Diabetes Canada/CSEM Professional Conference in Edmonton, Alberta, from November 1-4.

According to market research group Statista, nearly half the world's wheat is consumed as noodles, with China and Indonesia topping the list while a quarter is consumed as bread. The U.S. noodle market is worth US$270 million. The World Instant Noodles Association reports that global demand for instant noodles has declined from 106 billion servings in 2013 to 97.5 billion servings in 2016 as consumers continue to reduce the amount of processed foods, especially carbohydrates, from their diet.

The availability of low-GI noodles will provide consumers with a healthier option that does not compromise the taste and texture of the product. According to the Economist Intelligence Unit report on "Tackling obesity in ASEAN (South-East Asian Nations)", a low-GI diet was found to be the most effective among food-based interventions.

Holista Foods, headed by CEO, Ms Nadja Piatka, who has supplied healthier baked goods to major fast-food chains such as McDonald's and Subway, had announced in September 2016 its research efforts to develop the world's first low-GI noodles using Holista's low-GI ingredient, a patented formula that includes extracts of okra, dhal (lentils), barley and fenugreek.

Holista, a research-driven biotechnology and food ingredients company with operations in Australia and Malaysia, said it expects to conclude the first order for its low-GI noodles by November 2017.

In January 2016 Holista unveiled PANATURA(R)GI a patented formula co-developed with Veripan AG of Switzerland that achieved the world's lowest GI reading for clean-label flour-based bread. This product is in the late stage of commercialisation.

Holista Foods is also researching to develop low-GI mixes for muffins, cakes, cookies and pancakes. Holista has also commenced research on a low-GI formula for sugar.

Nadja Piatka, CEO of Holista Foods, said: "The fight against obesity and diabetes can be won with simple strategies such as empowering customers with better products. We are proud to make delicious, natural and healthier noodles widely available. In North America, there is a strong demand for noodles and healthier food options which do not compromise taste and texture. We are excited to roll-out the world's first clean label low-GI noodles in time for Diabetes Awareness Month in November, and World Diabetes Day on November 14."

Dr. Rajen Manicka, Chairman and CEO of Holista, said: "After the global launch of our low-GI bread formula we are excited with this breakthrough for noodles, a food staple widely consumed across Asia and the world. The implications for the noodle market and for the global battle against obesity could be significant."

About Holista CollTech Ltd

Holista CollTech Ltd ("Holista") is a research-driven biotech company and is the result of the merger of Holista Biotech Sdn Bhd and CollTech Australia Ltd. Headquartered in Perth with extensive operations in Malaysia, Holista is dedicated to delivering first-class natural ingredients and wellness products.

Holista, listed on the Australia Securities Exchange, researches, develops, manufactures and markets "health-style" products to address the unmet and growing needs of natural medicine. It is the only company to produce sheep (ovine) collagen using patented extraction methods, and is on track in nanonizing and encapsulating liposomes for the ovine collagen. Holista has suite of ingredients that is capable of serving the industry to provide low-GI baked products, low sodium salt, low fat fried foods and low calories sugar without compromise in taste, odour and mouth feel. For more information on Holista: www.holistaco.com

About Holista Foods, Inc.

Holista Foods is dedicated to developing and delivering clean label ingredients, finished food products and recipe development. The company specializes in next generation food research and development for improved taste and nutritional value.

Under the leadership of Nadja Piatka, Holista Foods is embracing a philosophy of providing great tasting, nutritional food products that will be readily available to all consumers. Nadja's original passion of providing healthy food products to consumers has carried over to low GI food innovations for an even healthier nutritional outcome.

Holista Foods is 74%-owned by Holista Colltech's 54%-held U.S. subsidiary LiteFoods of which it owns 53%. The remaining shares in Holista Foods are controlled by Nadja Piatka and Nadja Foods. Holista Foods, Inc. is based in Buffalo NY. For more information on Holista Foods, Inc., please visit www.holistafoods.com

For further information, please contact:
Corporate Affairs & Business Opportunities
Dr Rajen Manicka: rajen.m@holistaco.com
General Enquiries: enquiries@holistaco.com

Australia
283 Rokeby Road
Subiaco WA 6008
P: +61 8 6141 3500; F: +61 8 6141 3599

Malaysia
12th Floor, Amcorp Trade Centre, PJ Tower
No. 18, Persiaran Barat off Jalan Timur
46000, Petaling Jaya, Malaysia
P: +603 7965 2828; F: +603 7965 2777

Media and Investor Relations Enquiries
WeR1 Consultants Pte Ltd
3 Phillip Street #12-01
Singapore 048693
Roshan Singh, roshansingh@wer1.net; P: +65 67374844
Theresa Lam, theresalam@wer1.net; P: +603 2731 9244

Topic: Press release summary
Source: Holista CollTech Ltd / Holista Foods Inc.

Sectors: Food & Beverage, BioTech, Healthcare & Pharm, Cosmetics, Spec.Chem
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2023 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Holista CollTech Ltd Related News
Oct 12, 2021 17:00 HKT/SGT
Berjaya Partners Holista to Offer Healthy Breads and Foods in Starbucks Malaysia, 7-Eleven and Other F&B Outlets
June 18, 2021 14:00 HKT/SGT
Malaysia Permission Granted for COVID-19 Test Kit from China for Emergency Use; Homegrown Holista Colltech Receives Initial Order for 15,000 Units for Deployment
June 18, 2021 14:00 HKT/SGT
马来西亚允许了来自中国的新冠肺炎测试剂盒以供为紧急使用;Holista Colltech 收到 15,000 单位的初始订单
June 18, 2021 14:00 HKT/SGT
Malaysia Diberikan Kebenaran Untuk Kit Uji COVID-19 dari China Bagi Tujuan Penggunaan Kecemasan; Syarikat Tempatan Holista Colltech Menerima Pesanan Awal Sebanyak 15,000 Unit Untuk Penggunaan
June 18, 2021 14:00 HKT/SGT
馬來西亞允許了來自中國的新冠肺炎測試劑盒以供為緊急使用;Holista Colltech 收到 15,000 單位的初始訂單
More news >>
Copyright © 2023 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575